Shares of Bioceres Crop Solutions Corp. (NASDAQ:BIOX – Get Free Report) have received a consensus recommendation of “Hold” from the five analysts that are covering the stock, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and one has given a buy rating to the company. The average 12-month price objective among brokerages that have issued ratings on the stock in the last year is $4.00.
A number of brokerages have recently issued reports on BIOX. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Bioceres Crop Solutions in a research report on Monday, December 29th. Wall Street Zen upgraded Bioceres Crop Solutions from a “sell” rating to a “hold” rating in a research note on Saturday, November 22nd. Finally, Canaccord Genuity Group dropped their price target on Bioceres Crop Solutions from $2.25 to $2.00 and set a “hold” rating on the stock in a research note on Friday, January 2nd.
Check Out Our Latest Research Report on BIOX
Bioceres Crop Solutions Stock Down 2.5%
Institutional Inflows and Outflows
A number of hedge funds have recently bought and sold shares of the stock. Invesco Ltd. acquired a new stake in Bioceres Crop Solutions during the fourth quarter worth about $45,000. Ardsley Advisory Partners LP boosted its position in Bioceres Crop Solutions by 691.7% in the 4th quarter. Ardsley Advisory Partners LP now owns 475,000 shares of the company’s stock worth $622,000 after purchasing an additional 415,000 shares in the last quarter. GAM Holding AG acquired a new stake in shares of Bioceres Crop Solutions during the 4th quarter worth approximately $655,000. State of Wisconsin Investment Board purchased a new position in shares of Bioceres Crop Solutions during the 4th quarter valued at approximately $247,000. Finally, Marshall Wace LLP lifted its stake in shares of Bioceres Crop Solutions by 180.0% in the 4th quarter. Marshall Wace LLP now owns 595,410 shares of the company’s stock valued at $780,000 after purchasing an additional 382,744 shares during the period. Institutional investors and hedge funds own 17.68% of the company’s stock.
About Bioceres Crop Solutions
Bioceres Crop Solutions Corp. is an agricultural biotechnology company focused on developing, manufacturing and commercializing a range of crop inputs designed to enhance yields and improve sustainability. The company’s portfolio includes biological seed treatments, inoculants for nitrogen fixation, specialty fertilizers and proprietary biopesticides, which are formulated to support plant health and resilience under varying environmental conditions.
Among its flagship offerings is the HB4 drought-tolerant wheat technology, the first genetically modified wheat developed to withstand water stress, which has received regulatory approval in several markets.
Further Reading
- Five stocks we like better than Bioceres Crop Solutions
- Silver Crossed $100: Is the $500 surge next? (Join us March 4)
- America’s 1776 happening again
- 3 Signs You May Want to Switch Financial Advisors
- ATCX is Sitting on One of Brazil’s Largest Critical Minerals Portfolios!
- I’m 70 With $1.5M: Would Converting $120K a Year to a Roth Be Smart or a Costly Mistake? (Ask An Advisor)
Receive News & Ratings for Bioceres Crop Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioceres Crop Solutions and related companies with MarketBeat.com's FREE daily email newsletter.
